UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Detection of circulating tumor cells in different stages of prostate cancer

Journal of cancer research and clinical oncology, 2013-05, Vol.139 (5), p.755-763

2013

Volltextzugriff (PDF)

Topography of Lymph Node Metastases in Prostate Cancer Patients Undergoing Radical Prostatectomy and Extended Lymphadenectomy: Results of a Combined Molecular and Histopathologic Mapping Study

European urology, 2014-08, Vol.66 (2), p.222-229

2014

Volltextzugriff (PDF)

Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy

Urologia internationalis, 2016-01, Vol.96 (1), p.51-56

2016

Volltextzugriff (PDF)

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

BMC cancer, 2015-06, Vol.15 (1), p.458-458, Article 458

2015

Volltextzugriff (PDF)

Presurgical Treatment with Sunitinib for Renal Cell Carcinoma with a Level III/IV Vena Cava Tumour Thrombus

Anticancer research, 2012-05, Vol.32 (5), p.1729-1735

2012

Volltextzugriff (PDF)

Rational indication for docetaxel rechallenge in metastatic castration‐resistant prostate cancer

BJU international, 2012-12, Vol.110 (11b), p.E635-E640

2012

Volltextzugriff (PDF)

Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses

Urologic oncology, 2013-10, Vol.31 (7), p.1395-1401

2013

Volltextzugriff (PDF)

Not Available

MMW Fortschritte der Medizin, 2010-10, Vol.152 (41), p.40-44

Thalgott, Mark

2010

Volltextzugriff (PDF)

So bekommen Sie die Nebenwirkungen besser in den Griff: Hormonablative Therapie des Prostatakarzinoms

MMW Fortschritte der Medizin, 2010-10, Vol.152 (41), p.40-44

Thalgott, Mark

2010

Volltextzugriff (PDF)

So bekommen Sie die Nebenwirkungen besser in den Griff

MMW Fortschritte der Medizin, 2010-10, Vol.152 (41), p.40-44

Thalgott, Mark

2010

Volltextzugriff (PDF)

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

European urology, 2017-11, Vol.72 (5), p.828-834

2017

Volltextzugriff (PDF)

Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

European urology, 2015-09, Vol.68 (3), p.530-534

2015

Volltextzugriff (PDF)

Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years

Journal of cranio-maxillo-facial surgery, 2016-10, Vol.44 (10), p.1689-1693

2016

Volltextzugriff (PDF)

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients

European journal of nuclear medicine and molecular imaging, 2014-04, Vol.41 (4), p.694-701

2014

Volltextzugriff (PDF)

Chromogranin A and neurone‐specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration‐resistant prostate cancer undergoing abiraterone therapy

BJU international, 2017-01, Vol.119 (1), p.30-37

2017

Volltextzugriff (PDF)

One-Stop-Shop Whole-Body ^sup 68^Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer

The Journal of nuclear medicine (1978), 2018-12, Vol.59 (12), p.1850

2018

Volltextzugriff (PDF)

One-Stop-Shop Whole-Body 68 Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer

Journal of Nuclear Medicine, 2018-12, Vol.59 (12), p.1850-1856

2018

Volltextzugriff (PDF)

Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy

Anticancer research, 2015-10, Vol.35 (10), p.5679-5685

2015

Volltextzugriff (PDF)

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1

The Journal of urology, 2016-03, Vol.195 (3), p.771

2016

Volltextzugriff (PDF)

Operative Therapie des Harnblasenkarzinoms

Uro-news, 2016-12, Vol.20 (12), p.42-48

2016

Volltextzugriff (PDF)

One-stop shop whole-body ^sup 68^Ga-PSMA-11 PET/MRI compared to clinical Nomograms for preoperative T and N-Staging of High-Risk Prostate Cancer

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1502

2018

Volltextzugriff (PDF)

Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection

Clinical cancer research, 2018-05, Vol.24 (10), p.2342-2349

2018

Volltextzugriff (PDF)

Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer

European journal of nuclear medicine and molecular imaging, 2016-11, Vol.43 (12), p.2105-2113

2016

Volltextzugriff (PDF)

Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy

World journal of urology, 2018-02, Vol.36 (2), p.177-185

2018

Volltextzugriff (PDF)

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy

Prostate cancer and prostatic diseases, 2021-06, Vol.24 (2), p.362-369

2021

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of circulating tumor cells in different stages of prostate cancer

Topography of Lymph Node Metastases in Prostate Cancer Patients Undergoing Radical Prostatectomy and Extended Lymphadenectomy: Results of a Combined Molecular and Histopathologic Mapping Study

Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

Presurgical Treatment with Sunitinib for Renal Cell Carcinoma with a Level III/IV Vena Cava Tumour Thrombus

Rational indication for docetaxel rechallenge in metastatic castration‐resistant prostate cancer

Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses

Not Available

So bekommen Sie die Nebenwirkungen besser in den Griff: Hormonablative Therapie des Prostatakarzinoms

So bekommen Sie die Nebenwirkungen besser in den Griff

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients

Chromogranin A and neurone‐specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration‐resistant prostate cancer undergoing abiraterone therapy

One-Stop-Shop Whole-Body ^sup 68^Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer

One-Stop-Shop Whole-Body 68 Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer

Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1

Operative Therapie des Harnblasenkarzinoms

One-stop shop whole-body ^sup 68^Ga-PSMA-11 PET/MRI compared to clinical Nomograms for preoperative T and N-Staging of High-Risk Prostate Cancer

Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection

Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer

Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy

Suchergebnisse filtern